X
Xia Zhao
Researcher at Shanghai Jiao Tong University
Publications - 12
Citations - 504
Xia Zhao is an academic researcher from Shanghai Jiao Tong University. The author has contributed to research in topics: Acute promyelocytic leukemia & Diffuse large B-cell lymphoma. The author has an hindex of 7, co-authored 12 publications receiving 383 citations.
Papers
More filters
Journal ArticleDOI
Exome sequencing identifies somatic mutations of DDX3X in natural killer/T-cell lymphoma
Lu Jiang,Zhaohui Gu,Zi-Xun Yan,Xia Zhao,Yin-Yin Xie,Zi-Guan Zhang,Chun-Ming Pan,Yuan Hu,Chang-Ping Cai,Ying Dong,Jinyan Huang,Li Wang,Yang Shen,Guoyu Meng,Jianfeng Zhou,Jianda Hu,Jin-Fen Wang,Yuan-Hua Liu,Lin-Hua Yang,Feng Zhang,Jianmin Wang,Zhao Wang,Zhigang Peng,Fang-Yuan Chen,Zi-Min Sun,Hao Ding,Jumei Shi,Jian Hou,Jin-Song Yan,Jing-Yi Shi,Lan Xu,Yang Li,Jing Lu,Zhong Zheng,Wen Xue,Wei-Li Zhao,Zhu Chen,Sai-Juan Chen +37 more
TL;DR: This work identified somatic gene mutations in 25 people with NKTCL by whole-exome sequencing and confirmed them in an extended validation group of 80 people by targeted sequencing, contributing to the understanding of the disease mechanism ofNKTCL.
Journal ArticleDOI
Induction of autophagy by valproic acid enhanced lymphoma cell chemosensitivity through HDAC-independent and IP3-mediated PRKAA activation
Meng-Meng Ji,Li Wang,Qin Zhan,Wen Xue,Yan Zhao,Xia Zhao,Pengpeng Xu,Yang Shen,Han Liu,Anne Janin,Shu Cheng,Wei-Li Zhao +11 more
TL;DR: Findings suggested an HDAC-independent chemosensitizing activity of VPA and provided an insight into the clinical application of targeting autophagy in the treatment of lymphoma.
Journal ArticleDOI
The 12-year follow-up of survival, chronic adverse effects, and retention of arsenic in patients with acute promyelocytic leukemia.
Hongming Zhu,Jiong Hu,Li Chen,Wei Zhou,Xiaoyang Li,Lining Wang,Xia Zhao,Yunxiang Zhang,Huijin Zhao,Ai-Hua Wang,Yu Chen,Huiping Sun,Qiusheng Chen,Wei-Li Zhao,Jian-Qing Mi,Zhi-Xiang Shen,Zhen-Yi Wang,Zhu Chen,Sai-Juan Chen,Junmin Li +19 more
TL;DR: To the editor: Arsenic trioxide (ATO) and all-trans retinoic acid (ATRA) have demonstrated notable success in the treatment of acute promyelocytic leukemia (APL).
Journal ArticleDOI
A Phase II Study of Methotrexate, Etoposide, Dexamethasone and Pegaspargase Sandwiched with Radiotherapy in the Treatment of Newly Diagnosed, Stage IE to IIE Extranodal Natural-Killer/T-Cell Lymphoma, Nasal-Type.
P P Xu,Jie Xiong,Shu Cheng,Xia Zhao,Chao-Fu Wang,Gang Cai,Hui Juan Zhong,Heng Ye Huang,Jiayi Chen,Zhao Wl +9 more
TL;DR: MESA sandwiched with radiotherapy is an effective and safe regimen for early-stage ENKTL and asparaginase-associated metabolic score (AspM) may be a promising prognostic index of serum metabolites in addition to clinical prognostic Index in ENK TL.
Journal ArticleDOI
Anthracycline dose optimisation in patients with diffuse large B-cell lymphoma: a multicentre, phase 3, randomised, controlled trial.
Pengpeng Xu,Di Fu,Jianyong Li,Jianda Hu,Xin Wang,Jianfeng Zhou,Yu Hao,Xia Zhao,Yao-Hui Huang,Lu Jiang,Feng Liu,Li-Ping Su,Zhuo-Wen Chen,Qing-Shu Zeng,Jieping Chen,Mei-Yun Fang,Jun Ma,Ting Liu,Yongping Song,Kang Yu,Yan Li,Lugui Qiu,Xie-Qun Chen,Jian Gu,Jin-Song Yan,Ming Hou,Hengye Huang,Li Wang,Shu Cheng,Yang Shen,Xiong Hui,Sai-Juan Chen,Wei-Li Zhao +32 more
TL;DR: The non-inferiority margin for R-CEOP70 versus R-CHOP50 was met and adverse events were similar between the two groups, and analysis of efficacy and safety were of the intention-to-treat population.